Intech Biopharm Ltd - ESG Rating & Company Profile powered by AI
If you work at Intech Biopharm Ltd and you wish to use your ESG aseessment, please get in touch. The Sustainability rating for Intech Biopharm Ltd indicates the company's transparency towards the United Nations SDGs. Scroll down to the end of the page for potential risks for Intech Biopharm Ltd based on sector, geography and size.
Intech Biopharm Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Intech Biopharm Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Intech Biopharm Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Intech Biopharm Ltd disclose current and historical energy intensity?
Does Intech Biopharm Ltd report the average age of the workforce?
Does Intech Biopharm Ltd reference operational or capital allocation in relation to climate change?
Does Intech Biopharm Ltd disclose its ethnicity pay gap?
Does Intech Biopharm Ltd disclose cybersecurity risks?
Does Intech Biopharm Ltd offer flexible work?
Does Intech Biopharm Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Intech Biopharm Ltd disclose the number of employees in R&D functions?
Does Intech Biopharm Ltd conduct supply chain audits?
Does Intech Biopharm Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Intech Biopharm Ltd conduct 360 degree staff reviews?
Does Intech Biopharm Ltd disclose the individual responsible for D&I?
Does Intech Biopharm Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Intech Biopharm Ltd disclose current and / or historical scope 2 emissions?
Does Intech Biopharm Ltd disclose water use targets?
Does Intech Biopharm Ltd have careers partnerships with academic institutions?
Did Intech Biopharm Ltd have a product recall in the last two years?
Does Intech Biopharm Ltd disclose incidents of discrimination?
Does Intech Biopharm Ltd allow for Work Councils/Collective Agreements to be formed?
Has Intech Biopharm Ltd issued a profit warning in the past 24 months?
Does Intech Biopharm Ltd disclose parental leave metrics?
Does Intech Biopharm Ltd disclose climate scenario or pathway analysis?
Does Intech Biopharm Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Intech Biopharm Ltd disclose the pay ratio of women to men?
Does Intech Biopharm Ltd support suppliers with sustainability related research and development?
Does Intech Biopharm Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Intech Biopharm Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Intech Biopharm Ltd involved in embryonic stem cell research?
Does Intech Biopharm Ltd disclose GHG and Air Emissions intensity?
Does Intech Biopharm Ltd disclose its waste policy?
Does Intech Biopharm Ltd report according to TCFD requirements?
Does Intech Biopharm Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Intech Biopharm Ltd disclose energy use targets?
Does Intech Biopharm Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Intech Biopharm Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Intech Biopharm Ltd
These potential risks are based on the size, segment and geographies of the company.
Intech Biopharm Corporation focuses on developing and manufacturing generic drugs to treat respiratory diseases. It owns iLEF (inhaled low ethanol formulation), a metered dose inhaler platform for treating asthma and chronic pulmonary obstructive disease; and dry powder inhaler, a product comprises of blisters and capsules. The company offers its products under the SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011 names. Intech Biopharm Corporation was founded in 2010 and is headquartered in Taipei, Taiwan.